We are live on ! Find out more
AVXL icon

Anavex Life Sciences
AVXL

136 hedge funds and large institutions have $370M invested in Anavex Life Sciences in 2021 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 46 increasing their positions, 29 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

65% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 17

59% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 29

7% more funds holding

Funds holding: 127 → 136 (+9)

5% more call options, than puts

Call options by funds: $19M | Put options by funds: $18.2M

2.64% less ownership

Funds ownership: 29.86% → 27.22% (-2.6%)

25% less capital invested

Capital invested by funds: $495M → $370M (-$125M)

Holders
136
Holders Change
+9
Holders Change %
+7.09%
% of All Funds
2.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
46
Reduced
29
Closed
17
Calls
$19M
Puts
$18.2M
Net Calls
+$840K
Net Calls Change
+$667K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$6.83M
2
Charles Schwab
Charles Schwab
California
+$6.77M
3
PC
Pier Capital
Connecticut
+$5.5M
4
UBS Group
UBS Group
Switzerland
+$3.44M
5
Nomura Holdings
Nomura Holdings
Japan
+$2.99M

Top Sellers

Rank Fund Capital Flow
1
GLA
Great Lakes Advisors
Illinois
-$15.5M
2
Invesco
Invesco
Georgia
-$11.2M
3
First Trust Advisors
First Trust Advisors
Illinois
-$4.07M
4
EI
EAM Investors
California
-$4.06M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$3.86M
Name Holding Trade Value Shares
Change 		Change in
Stake
LSA
101
Leonteq Securities AG
Switzerland
$100K +$51.2K +2,570 +86%
APA
102
American Portfolios Advisors
New York
$98.7K – – –
AIP
103
Ameritas Investment Partners
Nebraska
$87K – – –
OSAM
104
O'Shaughnessy Asset Management
Connecticut
$78K -$69K -3,468 -44%
KFS
105
Kelly Financial Services
Massachusetts
$71.8K -$1.74M -87,440 -96%
EW
106
Evoke Wealth
California
$68K – – –
PHK
107
Point72 Hong Kong
Hong Kong
$64K +$71.3K +3,581 New
CFA
108
Cahill Financial Advisors
Minnesota
$63K +$69.7K +3,500 New
SWM
109
Spire Wealth Management
Virginia
$50K +$2.99K +150 +6%
Fidelity Investments
110
Fidelity Investments
Massachusetts
$46K +$49.6K +2,492 +5,538%
FCA
111
FinTrust Capital Advisors
South Carolina
$44K +$48.3K +2,425 New
CG
112
Cutler Group
California
$44K +$49.8K +2,500 New
IA
113
IFP Advisors
Florida
$36K – – –
PNC Financial Services Group
114
PNC Financial Services Group
Pennsylvania
$36K – – –
BFC
115
Bedel Financial Consulting
Indiana
$22K – – –
Rockefeller Capital Management
116
Rockefeller Capital Management
New York
$21K +$7.96K +400 +50%
Macquarie Group
117
Macquarie Group
Australia
$20K – – –
CAPTRUST Financial Advisors
118
CAPTRUST Financial Advisors
North Carolina
$18K -$8.5K -427 -30%
CAM
119
Costello Asset Management
Pennsylvania
$18K – – –
DWA
120
Delos Wealth Advisors
Texas
$18K – – –
VRM
121
Vectors Research Management
New York
$18K – – –
NSIM
122
North Star Investment Management
Illinois
$18K +$19.9K +1,000 New
LFG
123
Larson Financial Group
Missouri
$10K – – –
CA
124
Clearstead Advisors
Ohio
$9K – – –
MAM
125
Meeder Asset Management
Ohio
$8K – – –
3 4
5
6 7

AVXL Hedge Fund Activity: Q3 2021 in Review

136 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q3 2021, worth a combined $370M — down 25% from $495M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new AVXL positions and 17 closed out — a net gain of 11 holders — while 46 added to existing stakes and 29 trimmed.

The largest buyer was Vanguard Group, adding an estimated $6.83M. The largest seller was Great Lakes Advisors, exiting entirely with an estimated $15.5M sold.

  • 136 institutional investors held Anavex Life Sciences (AVXL) as of Q3 2021, up from 127 in Q2 2021.
  • Funds reported $370M of Anavex Life Sciences stock for Q3 2021, down 25% quarter-over-quarter.
  • 28 funds opened new Anavex Life Sciences positions in Q3 2021 and 17 closed out, a net change of +11 holders.
  • The largest Anavex Life Sciences buyer in Q3 2021 was Vanguard Group, an estimated $6.83M added.
  • The largest Anavex Life Sciences seller in Q3 2021 was Great Lakes Advisors, an estimated $15.5M sold.

Based on aggregated 13F filings for Q3 2021.